Hillsdale Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Hillsdale Investment Management's DGX Position: Q2 2021 in Review
Hillsdale Investment Management sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 4,220 shares — an estimated $542K sold.
Hillsdale Investment Management first reported a position in DGX in Q1 2015 and held it in 17 quarters. The position peaked at $542K in Q1 2021. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.
- Hillsdale Investment Management reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
- Hillsdale Investment Management sold 4,220 Quest Diagnostics shares in Q2 2021, an estimated $542K.
- Hillsdale Investment Management first reported a position in Quest Diagnostics in Q1 2015 and held it in 17 quarters.
- Hillsdale Investment Management's Quest Diagnostics position peaked at $542K in Q1 2021.
- 815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.
Based on Hillsdale Investment Management's 13F filing for Q2 2021, filed 29 Jul 2021.